Connect with us

Hi, what are you looking for?

Jewish Business News


Israel’s 13th Nobel laureate: Joshua Angrist wins 2021 Nobel Prize in Economics

was a frontrunner for the Nobel Prize in 2019. He is the third in economics, alongside Daniel Kahneman, and Robert Aumann

Joshua Angrist
Joshua Angrist

Israeli-American Joshua Angrist, professor at the Massachusetts Institute of Technology (MIT), has been awarded the 2021 Nobel Prize in Economics.

Angris will share the prize with Guido Imbens and David Card “for their methodological contributions to the analysis of causal relationships.”

According to NBC, the Nobel Institute stated that the three laureates “gave us with new insights into the labor market and demonstrated how causal inferences may be formed from natural experiments.”

Angrist was born in Columbus, Ohio. He earned a master’s degree in economics and a doctorate in economics from Princeton University in 1987 and 1989, respectively. He later worked at Harvard University and the Hebrew University of Jerusalem before coming to the Massachusetts Institute of Technology (MIT), where he continues to work today.

He has conducted various studies on labor economics and the economics of education throughout his career, the latter of which included research on schools in Israel, the West Bank, Gaza, the United States, Colombia, and Canada.

Angrist has kept an active career, continuing to write papers and give seminars, as well as releasing a Q&A video series on common economics problems and misconceptions through Marvinal Revolution University, which can be viewed on YouTube.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


Now Platika joins and elite club of $10 billion plus Israeli firms.